C. Rygaard

发表

Referral population studies underestimate differences between human papillomavirus assays in primary cervical screening

E. Lynge, M. Rebolj, S. Njor, 2017, Cytopathology : official journal of the British Society for Clinical Cytology.

Cervical cancer survivors and health care use: A Danish population-based register study.

Miguel Vazquez-Prada Baillet, J. Hallas, P. T. Jensen, 2021, Gynecologic oncology.

Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study

E. Lynge, M. Rebolj, S. Preisler, 2016, BMC Cancer.

Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays

E. Lynge, M. Rebolj, S. Preisler, 2016, Journal of Clinical Microbiology.

Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above

E. Lynge, M. Rebolj, S. Preisler, 2016, PloS one.

Comparison of three human papillomavirus DNA assays and one mRNA assay in women with abnormal cytology.

E. Lynge, M. Rebolj, S. Preisler, 2014, Gynecologic oncology.

Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening

E. Lynge, M. Rebolj, S. Preisler, 2014, PloS one.

Cervical cancer screening at crossroads

Miguel Vazquez-Prada Baillet, E. Lynge, M. Rebolj, 2014, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Outcomes in cervical screening using various cytology technologies: What’s age got to do with it?

E. Lynge, M. Rebolj, C. Rygaard, 2013, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders

S. Kjaer, E. Lynge, M. Rebolj, 2017, Journal of Clinical Microbiology.

A daunting challenge: Human Papillomavirus assays and cytology in primary cervical screening of women below age 30years.

E. Lynge, M. Rebolj, S. Preisler, 2015, European journal of cancer.

Prevalence of Human Papillomavirus infection in unselected SurePath samples using the APTIMA HPV mRNA assay.

E. Lynge, M. Rebolj, S. Preisler, 2013, The Journal of molecular diagnostics : JMD.

Human papillomavirus self‐sampling for screening nonattenders: Opt‐in pilot implementation with electronic communication platforms

E. Lynge, M. Rebolj, C. Rygaard, 2017, International journal of cancer.

Management of low-grade CIN: follow-up or treatment?

C. Rygaard, J. Junge, F. Lundvall, 1995, European journal of obstetrics, gynecology, and reproductive biology.

Patterns of cervical coinfection with multiple human papilloma virus types in a screening population in Denmark.

E. Lynge, M. Rebolj, S. Preisler, 2013, Vaccine.

Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay

E. Lynge, M. Rebolj, S. Preisler, 2013, PloS one.

Conization and healthcare use: a population-based register study

J. Hallas, P. T. Jensen, E. Lynge, 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Abnormal cervical cytology and health care use: a population-based register study.

Miguel Vazquez-Prada Baillet, J. Hallas, P. T. Jensen, 2015, Gynecologic oncology.

Impact of technology on cytology outcome in cervical cancer screening of young and older women

E. Lynge, M. Rebolj, C. Rygaard, 2014, International journal of cancer.

Cervical screening in Denmark – a success followed by stagnation

E. Mikkelsen, J. K. Kristensen, E. Lynge, 2017, Acta oncologica.

Thermal balloon endometrial ablation: safety aspects evaluated by serosal temperature, light microscopy and electron microscopy.

B. Ottesen, C. Rygaard, J. Junge, 1998, European journal of obstetrics, gynecology, and reproductive biology.

Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study

E. Lynge, M. Rebolj, S. Preisler, 2016, BMC Cancer.

HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 Human Papillomavirus genotype microarray system

E. Lynge, M. Rebolj, S. Preisler, 2014, BMC Infectious Diseases.

Screening history in women with cervical cancer in a Danish population-based screening program.

C. Rygaard, B. Kirschner, J. Junge, 2011, Gynecologic oncology.

Danish method study on cervical screening in women offered HPV vaccination as girls (Trial23): a study protocol

E. Lynge, C. Rygaard, L. Larsen, 2018, BMJ Open.

Human papillomavirus self-sampling for screening nonattenders

E. Lynge, M. Rebolj, D. Ejegod, 2018 .

Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark

M. van Ballegooijen, E. Lynge, M. Rebolj, 2015, British Journal of Cancer.

SYNTHESIS OF DATA TOWARDS NECK PROTECTION CRITERIA FOR CHILDREN

I Planath, C Rygaard, S Nilsson, 1992 .

Prevalence of high‐risk human papillomavirus after HPV‐vaccination in Denmark

E. Lynge, C. Rygaard, L. Larsen, 2020, International journal of cancer.

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders

J. Dillner, S. Kjær, E. Lynge, 2017, British Journal of Cancer.

University of Southern Denmark Prevalence of high-risk human papillomavirus after HPV-vaccination in Denmark Lynge,

E. Lynge, C. Rygaard, L. Larsen, 2020 .

Isotonic dextrose and isotonic saline as solvents for intravenous treatment of premature labour with ritodrine

C. Rygaard, S. Lenz, L. Vejerslev, 1985 .